Cargando…

CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

CD24 has been described as an adverse prognostic marker in several malignancies. This study evaluates CD24 expression in cholangiocarcinoma and correlates the findings with clinicopathologic data and patient survival. Between 1996 and 2002, 22 consecutive patients with cholangiocarcinoma were treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Shefali, Kuvshinoff, Boris W., Khoury, Thaer, Yu, Jihnhee, Javle, Milind M., LeVea, Charles, Groth, Jeff, Coignet, Lionel J., Gibbs, John F.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852393/ https://www.ncbi.nlm.nih.gov/pubmed/17436128 http://dx.doi.org/10.1007/s11605-007-0091-5

Ejemplares similares

Oral Floor and Gingival Metastasis of Cholangiocarcinoma: A Case Report and Review of the Literature
por: Nakanishi, Yukihiro, et al.
Publicado: (2014)

Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study
por: Samuel, Sandeep, et al.
Publicado: (2018)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma
por: Fountzilas, Christos, et al.
Publicado: (2023)

Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
por: Javle, M, et al.
Publicado: (2009)

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers
por: Connor, Ashton A., et al.
Publicado: (2022)

Case reports on a gastric mass presenting with regional lymphadenopathy: A differential diagnosis is gastric schwannoma
por: Wadhawan, Arnav, et al.
Publicado: (2020)

Modulating gut immunity and neoplasia with oral cytokine adjuvants
por: Ozbilge, Hatice, et al.
Publicado: (2015)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017
por: Javle, Milind, et al.
Publicado: (2022)

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
por: Churi, Chaitanya R., et al.
Publicado: (2014)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Evolving Ablative Therapies for Hepatic Malignancy
por: Singla, Smit, et al.
Publicado: (2014)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Updates in Gastrointestinal Oncology – insights from the 2008 44(th )annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2009)

Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2010)

Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions
por: Khoury, Thaer
Publicado: (2022)

The Evolving Approach to Breast Cancer: Moving toward De-Escalating Treatment and Personalized Medicine
por: Khoury, Thaer
Publicado: (2023)

Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients
por: Cao, Jingyu, et al.
Publicado: (2020)

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
por: Zhang, H, et al.
Publicado: (2014)

CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2
por: LEELAWAT, KAWIN, et al.
Publicado: (2013)

Gastrointestinal Stromal Tumor: Chondro-Myxoid Variant Mimicking Chondrosarcoma
por: Rajput, Ashwani, et al.
Publicado: (2005)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study
por: Coignet, Marie V., et al.
Publicado: (2017)

Life-threatening Development of Cardiac Tamponade in the Span of 24 Hours
por: Kishi, Patrick, et al.
Publicado: (2019)

High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma
por: Lertpanprom, Muntinee, et al.
Publicado: (2022)

Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population
por: Ma, Lixing, et al.
Publicado: (2023)

ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022)

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
por: Pappas, Leontios, et al.
Publicado: (2023)

Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
por: DiPeri, Timothy P., et al.
Publicado: (2022)

Umbilical Nodule in Cholangiocarcinoma
por: Agrawal, Vivek, et al.
Publicado: (2012)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2021)

Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials
por: Subbiah, Ishwaria M., et al.
Publicado: (2013)

CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma
por: Nair, Amit, et al.
Publicado: (2020)

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
por: Javle, Milind, et al.
Publicado: (2023)

Cancer review: Cholangiocarcinoma
por: Ghouri, Yezaz Ahmed, et al.
Publicado: (2015)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Identification of CD24 as a marker for tumorigenesis of melanoma
por: Tang, Ming-Rui, et al.
Publicado: (2018)

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
por: De, Brian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sopt8107jl1tujtbs32e1gtone